node,label,type,community
acoustic neuroma,acoustic neuroma,disease,17
radiation therapy,radiation therapy,treatment,2
nf2,nf2,gene,17
scan,scan,diagnosis,17
tonsillitis,tonsillitis,disease,0
crest,crest,treatment,0
fluid,fluid,treatment,0
humidifier,humidifier,treatment,0
tonsillectomy,tonsillectomy,treatment,0
viral infection,viral infection,cause,0
bacterial infection,bacterial infection,cause,0
obsolete streptococcal pharyngitis,obsolete streptococcal pharyngitis,cause,0
adenoid cystic carcinoma,adenoid cystic carcinoma,disease,1
adjuvant radiotherapy,adjuvant radiotherapy,treatment,1
palliative radiation therapy,palliative radiation therapy,treatment,1
myb,myb,gene,1
nfib,nfib,gene,1
mybl1,mybl1,gene,1
adrenal gland cancer,adrenal gland cancer,disease,2
surgery,surgery,treatment,2
chemotherapy,chemotherapy,treatment,2
adrenocortical carcinoma,adrenocortical carcinoma,subtype,1
neuroblastoma,neuroblastoma,subtype,2
pheochromocytoma,pheochromocytoma,subtype,3
genetic counseling,genetic counseling,treatment,1
tp53,tp53,gene,5
ctnnb1,ctnnb1,gene,4
men1,men1,gene,1
prkar1a,prkar1a,gene,1
rpl22,rpl22,gene,1
daxx,daxx,gene,1
tert,tert,gene,2
znrf3,znrf3,gene,1
cdkn2a,cdkn2a,gene,1
h19,h19,gene,8
magnetic resonance imaging of bone,magnetic resonance imaging of bone,diagnosis,1
positron emission tomography,positron emission tomography,diagnosis,1
ctnnb1 gene mutation,ctnnb1 gene mutation,cause,4
men1 gene mutation,men1 gene mutation,cause,1
prkar1a gene mutation,prkar1a gene mutation,cause,1
daxx gene mutation,daxx gene mutation,cause,1
ret gene amplification,ret gene amplification,cause,1
homozygous cdkn2a gene deletion,homozygous cdkn2a gene deletion,cause,1
family history of marfan syndrome,family history of marfan syndrome,risk_factor,1
tp53 gene mutation,tp53 gene mutation,risk_factor,5
adrenal cortical oncocytic carcinoma,adrenal cortical oncocytic carcinoma,subtype,1
adrenal cortical myxoid carcinoma,adrenal cortical myxoid carcinoma,subtype,1
carcinosarcoma,carcinosarcoma,subtype,9
primary pigmented nodular adrenocortical disease 1,primary pigmented nodular adrenocortical disease 1,subtype,1
anal cancer,anal cancer,disease,4
cisplatin,cisplatin,treatment,15
carboplatin,carboplatin,treatment,4
doxorubicin,doxorubicin,treatment,9
capecitabine,capecitabine,treatment,4
physical examination,physical examination,diagnosis,22
digital rectal examination,digital rectal examination,diagnosis,4
proctoscopy,proctoscopy,diagnosis,4
cigarette smoking,cigarette smoking,risk_factor,4
adenocarcinoma,adenocarcinoma,subtype,4
small cell carcinoma,small cell carcinoma,subtype,4
melanoma,melanoma,subtype,18
cloacogenic carcinoma,cloacogenic carcinoma,subtype,4
anaplastic thyroid cancer,anaplastic thyroid cancer,disease,2
targeted therapy,targeted therapy,treatment,13
pax8,pax8,gene,2
braf,braf,gene,2
biopsy,biopsy,diagnosis,2
fine-needle aspiration,fine-needle aspiration,diagnosis,13
angiosarcoma,angiosarcoma,disease,14
von willebrand factor human,von willebrand factor human,diagnosis,14
vascular endothelial growth factor receptor,vascular endothelial growth factor receptor,diagnosis,14
arsenic exposure,arsenic exposure,risk_factor,14
thorotrast exposure,thorotrast exposure,risk_factor,14
breast implant,breast implant,risk_factor,14
ultraviolet radiation,ultraviolet radiation,risk_factor,14
neurofibromatosis,neurofibromatosis,risk_factor,14
maffucci syndrome,maffucci syndrome,risk_factor,14
klippel-trenaunay syndrome,klippel-trenaunay syndrome,risk_factor,14
primary breast angiosarcoma,primary breast angiosarcoma,subtype,14
soft tissue angiosarcoma,soft tissue angiosarcoma,subtype,14
appendix cancer,appendix cancer,disease,9
appendectomy,appendectomy,treatment,9
right colectomy,right colectomy,treatment,9
cytoreductive surgery,cytoreductive surgery,treatment,9
hyperthermic intraperitoneal chemotherapy,hyperthermic intraperitoneal chemotherapy,treatment,9
gastric gastrointestinal stromal tumor,gastric gastrointestinal stromal tumor,subtype,9
mucinous adenocarcinoma,mucinous adenocarcinoma,subtype,9
signet ring cell adenocarcinoma,signet ring cell adenocarcinoma,subtype,9
appendix mucinous neoplasm,appendix mucinous neoplasm,subtype,9
astroblastoma,astroblastoma,disease,15
craniotomy,craniotomy,treatment,15
etoposide,etoposide,treatment,15
vincristine,vincristine,treatment,15
ifosfamide,ifosfamide,treatment,9
temozolomide,temozolomide,treatment,15
stem cell therapy,stem cell therapy,treatment,15
gfap,gfap,gene,15
cd33,cd33,gene,15
histology,histology,diagnosis,15
comparative genomic hybridization,comparative genomic hybridization,diagnosis,15
anaplastic astrocytoma,anaplastic astrocytoma,subtype,15
astrocytoma,astrocytoma,disease,2
atypical teratoid rhabdoid tumor,atypical teratoid rhabdoid tumor,disease,20
intrathecal chemotherapy,intrathecal chemotherapy,treatment,20
smarcb1,smarcb1,gene,20
opn3,opn3,gene,20
bone marrow aspiration,bone marrow aspiration,diagnosis,20
bone marrow biopsy,bone marrow biopsy,diagnosis,20
bone scan,bone scan,diagnosis,3
germline samd9 gene mutation,germline samd9 gene mutation,cause,20
chromosomal deletion,chromosomal deletion,cause,20
smarcb1 gene mutation,smarcb1 gene mutation,cause,20
posterior cranial fossa,posterior cranial fossa,subtype,20
basal-cell carcinoma,basal-cell carcinoma,disease,8
mohs surgery,mohs surgery,treatment,8
electrodessication and curettage,electrodessication and curettage,treatment,8
cryosurgery,cryosurgery,treatment,8
photodynamic therapy,photodynamic therapy,treatment,8
laser surgery,laser surgery,treatment,8
external beam radiation therapy,external beam radiation therapy,treatment,8
brachytherapy,brachytherapy,treatment,8
systemic chemotherapy,systemic chemotherapy,treatment,8
vismodegib,vismodegib,treatment,8
sonidegib,sonidegib,treatment,8
itraconazole,itraconazole,treatment,8
biological therapy,biological therapy,treatment,8
ptch1,ptch1,gene,8
smo,smo,gene,5
skin examination,skin examination,diagnosis,8
shave biopsy,shave biopsy,diagnosis,8
gene mutation,gene mutation,cause,20
ptch1 gene mutation,ptch1 gene mutation,cause,8
smo gene mutation,smo gene mutation,cause,8
fair skin,fair skin,risk_factor,8
family history of ovarian cancer,family history of ovarian cancer,risk_factor,9
prior radiation therapy,prior radiation therapy,risk_factor,8
cholangiocarcinoma,cholangiocarcinoma,disease,14
liver transplantation,liver transplantation,treatment,14
adjuvant therapy,adjuvant therapy,treatment,14
fgfr2,fgfr2,gene,14
idh1,idh1,gene,5
percutaneous transhepatic cholangiography,percutaneous transhepatic cholangiography,diagnosis,14
histopathologic examination,histopathologic examination,diagnosis,5
immunocytochemistry,immunocytochemistry,diagnosis,17
primary sclerosing cholangitis,primary sclerosing cholangitis,risk_factor,10
ulcerative colitis,ulcerative colitis,risk_factor,14
cirrhosis,cirrhosis,risk_factor,14
hepatitis c,hepatitis c,risk_factor,14
hepatitis b,hepatitis b,risk_factor,14
hiv infection,hiv infection,risk_factor,10
lynch syndrome 1,lynch syndrome 1,risk_factor,14
biliary papillomatosis,biliary papillomatosis,risk_factor,14
intrahepatic cholangiocarcinoma,intrahepatic cholangiocarcinoma,subtype,14
hilar cholangiocarcinoma,hilar cholangiocarcinoma,subtype,14
whipple procedure,whipple procedure,treatment,14
partial hepatectomy,partial hepatectomy,treatment,14
gemcitabine,gemcitabine,treatment,9
irinotecan,irinotecan,treatment,14
erlotinib,erlotinib,treatment,14
transarterial chemoembolization,transarterial chemoembolization,treatment,14
transarterial radioembolization,transarterial radioembolization,treatment,14
ablation therapy,ablation therapy,treatment,14
magnetic resonance cholangiopancreatography,magnetic resonance cholangiopancreatography,diagnosis,14
liver function test,liver function test,diagnosis,2
endoscopic ultrasound biopsy,endoscopic ultrasound biopsy,diagnosis,14
cholestasis,cholestasis,cause,14
hepatitis c infection,hepatitis c infection,risk_factor,15
hepatitis b infection,hepatitis b infection,risk_factor,14
alcoholic liver disease,alcoholic liver disease,risk_factor,14
klatskin's tumor,klatskin's tumor,subtype,14
bladder cancer,bladder cancer,disease,16
transurethral resection of bladder tumor,transurethral resection of bladder tumor,treatment,16
radical cystectomy,radical cystectomy,treatment,16
partial cystectomy,partial cystectomy,treatment,16
clinical trial,clinical trial,treatment,16
rb1,rb1,gene,8
pten,pten,gene,16
mlh1,mlh1,gene,16
msh2,msh2,gene,16
msh6,msh6,gene,16
pms2,pms2,gene,16
nat2,nat2,gene,16
gstm1,gstm1,gene,16
ugt1a6,ugt1a6,gene,16
tp63,tp63,gene,16
ccne1,ccne1,gene,16
myc,myc,gene,16
fgfr3,fgfr3,gene,8
nbn,nbn,gene,16
xrcc1,xrcc1,gene,16
xrcc3,xrcc3,gene,16
ercc2,ercc2,gene,16
ercc4,ercc4,gene,16
ercc5,ercc5,gene,16
pik3ca,pik3ca,gene,16
erbb2,erbb2,gene,16
erbb3,erbb3,gene,16
tsc1,tsc1,gene,16
cdh1,cdh1,gene,10
cystoscopy,cystoscopy,diagnosis,2
urine cytology,urine cytology,diagnosis,16
tnm staging system,tnm staging system,diagnosis,16
smoking tobacco,smoking tobacco,cause,13
smoking,smoking,risk_factor,2
family history of breast cancer,family history of breast cancer,risk_factor,16
schistosomiasis,schistosomiasis,risk_factor,16
urothelial carcinoma,urothelial carcinoma,subtype,16
transitional cell carcinoma,transitional cell carcinoma,subtype,9
squamous cell carcinoma,squamous cell carcinoma,subtype,13
sarcoma,sarcoma,subtype,2
in situ carcinoma,in situ carcinoma,subtype,2
bone cancer,bone cancer,disease,2
x-ray,x-ray,diagnosis,3
gel electrophoresis,gel electrophoresis,diagnosis,2
osteosarcoma,osteosarcoma,subtype,16
chondrosarcoma,chondrosarcoma,subtype,2
ewing sarcoma,ewing sarcoma,subtype,21
fibrosarcoma,fibrosarcoma,subtype,2
multiple myeloma,multiple myeloma,subtype,7
chronic lymphocytic leukemia,chronic lymphocytic leukemia,disease,20
immunotherapy,immunotherapy,treatment,20
bone marrow transplantation,bone marrow transplantation,treatment,20
stem cell transplant source,stem cell transplant source,treatment,20
lymph node biopsy,lymph node biopsy,diagnosis,20
brain tumor,brain tumor,disease,5
monitoring,monitoring,treatment,5
idh2,idh2,gene,5
atrx,atrx,gene,5
egfr,egfr,gene,16
medical examination,medical examination,diagnosis,5
clinical investigation,clinical investigation,diagnosis,5
diffusion weighted imaging,diffusion weighted imaging,diagnosis,5
epstein-barr virus,epstein-barr virus,risk_factor,10
ionizing radiation,ionizing radiation,risk_factor,16
cancer,cancer,subtype,5
glioma,glioma,subtype,5
meningioma,meningioma,subtype,5
pituitary adenoma,pituitary adenoma,subtype,9
peripheral nerve sheath neoplasm,peripheral nerve sheath neoplasm,subtype,5
glioblastoma,glioblastoma,subtype,5
medulloblastoma,medulloblastoma,subtype,15
oligodendroglioma,oligodendroglioma,subtype,5
anaplastic oligodendroglioma,anaplastic oligodendroglioma,subtype,5
central neurocytoma,central neurocytoma,subtype,5
choroid plexus carcinoma,choroid plexus carcinoma,subtype,5
choroid plexus papilloma,choroid plexus papilloma,subtype,5
choroid plexus cancer,choroid plexus cancer,subtype,5
dysembryoplastic neuroepithelial tumor,dysembryoplastic neuroepithelial tumor,subtype,5
ependymal tumor,ependymal tumor,subtype,5
fibrillary astrocytoma,fibrillary astrocytoma,subtype,5
gliomatosis cerebri,gliomatosis cerebri,subtype,5
gliosarcoma,gliosarcoma,subtype,5
hemangiopericytoma,hemangiopericytoma,subtype,5
medulloepithelioma,medulloepithelioma,subtype,5
meningeal carcinomatosis,meningeal carcinomatosis,subtype,5
pulmonary sclerosing hemangioma,pulmonary sclerosing hemangioma,subtype,5
oligoastrocytoma,oligoastrocytoma,subtype,5
optic nerve sheath meningioma,optic nerve sheath meningioma,subtype,5
pilocytic astrocytoma,pilocytic astrocytoma,subtype,5
pineoblastoma,pineoblastoma,subtype,5
pineocytoma,pineocytoma,subtype,5
pleomorphic xanthoastrocytoma,pleomorphic xanthoastrocytoma,subtype,5
refractory central nervous system lymphoma,refractory central nervous system lymphoma,subtype,5
subependymal giant cell astrocytoma,subependymal giant cell astrocytoma,subtype,5
subependymoma,subependymoma,subtype,5
trilateral retinoblastoma,trilateral retinoblastoma,subtype,8
breast cancer,breast cancer,disease,16
brca1,brca1,gene,9
brca2,brca2,gene,9
herc2,herc2,gene,16
palb2,palb2,gene,16
plb1,plb1,gene,16
gata3,gata3,gene,3
sentinel lymph node biopsy,sentinel lymph node biopsy,diagnosis,8
g-protein coupled estrogen receptor 1,g-protein coupled estrogen receptor 1,cause,16
obesity,obesity,risk_factor,16
diabetes mellitus,diabetes mellitus,risk_factor,16
klinefelter syndrome,klinefelter syndrome,risk_factor,22
breast ductal carcinoma,breast ductal carcinoma,subtype,16
invasive lobular carcinoma,invasive lobular carcinoma,subtype,16
mammary paget's disease,mammary paget's disease,subtype,16
ductal carcinoma in situ,ductal carcinoma in situ,subtype,16
lobular neoplasia,lobular neoplasia,subtype,16
tubular adenocarcinoma,tubular adenocarcinoma,subtype,16
obsolete medullary carcinoma,obsolete medullary carcinoma,subtype,16
papillary carcinoma,papillary carcinoma,subtype,16
triple-negative breast cancer finding,triple-negative breast cancer finding,subtype,16
carcinoid syndrome,carcinoid syndrome,disease,6
carcinoid tumor,carcinoid tumor,disease,2
history and physical exam,history and physical exam,diagnosis,2
achlorhydria,achlorhydria,risk_factor,2
autoimmune thyroiditis,autoimmune thyroiditis,risk_factor,2
pernicious anemia,pernicious anemia,risk_factor,2
gastrointestinal carcinoma,gastrointestinal carcinoma,subtype,2
lung carcinoma,lung carcinoma,subtype,2
neuroendocrine cell,neuroendocrine cell,subtype,2
kras,kras,gene,9
adenosarcoma,adenosarcoma,subtype,9
uterine angiosarcoma,uterine angiosarcoma,subtype,9
castleman disease,castleman disease,disease,10
unicentric castleman disease,unicentric castleman disease,subtype,10
multicentric castleman disease,multicentric castleman disease,subtype,10
cervical cancer,cervical cancer,disease,4
adenosquamous carcinoma,adenosquamous carcinoma,subtype,4
neuroendocrine tumor,neuroendocrine tumor,subtype,4
glassy cell carcinoma,glassy cell carcinoma,subtype,4
cervical villoglandular adenocarcinoma,cervical villoglandular adenocarcinoma,subtype,4
gastric mucinous adenocarcinoma,gastric mucinous adenocarcinoma,subtype,4
chordoma,chordoma,disease,16
amputation,amputation,treatment,16
carbon ion radiotherapy,carbon ion radiotherapy,treatment,16
pemetrexed,pemetrexed,treatment,16
pembrolizumab,pembrolizumab,treatment,13
afatinib,afatinib,treatment,16
lapatinib,lapatinib,treatment,16
imatinib,imatinib,treatment,16
tsc2,tsc2,gene,16
akt1,akt1,gene,16
eif4ebp1,eif4ebp1,gene,16
pdgfrb,pdgfrb,gene,17
age between 80 and 85 years,age between 80 and 85 years,risk_factor,21
conventional chordoma,conventional chordoma,subtype,16
chondroid chordoma,chondroid chordoma,subtype,16
dedifferentiated chordoma,dedifferentiated chordoma,subtype,16
choriocarcinoma,choriocarcinoma,disease,11
methotrexate,methotrexate,treatment,11
dactinomycin,dactinomycin,treatment,11
hysterectomy,hysterectomy,treatment,11
hydatidiform mole,hydatidiform mole,cause,11
spontaneous abortion,spontaneous abortion,cause,11
ectopic pregnancy,ectopic pregnancy,cause,11
normal pregnancy,normal pregnancy,cause,11
hyperemesis gravidarum,hyperemesis gravidarum,cause,11
gestational choriocarcinoma,gestational choriocarcinoma,subtype,11
testicular choriocarcinoma,testicular choriocarcinoma,subtype,11
ovarian choriocarcinoma,ovarian choriocarcinoma,subtype,11
chronic myeloid leukemia,chronic myeloid leukemia,disease,20
tyrosine kinase inhibitor,tyrosine kinase inhibitor,treatment,15
imatinib mesylate,imatinib mesylate,treatment,20
dasatinib,dasatinib,treatment,20
nilotinib,nilotinib,treatment,20
radotinib,radotinib,treatment,20
bosutinib,bosutinib,treatment,20
asciminib,asciminib,treatment,20
ponatinib,ponatinib,treatment,20
high-dose chemotherapy with stem cell support,high-dose chemotherapy with stem cell support,treatment,20
allogeneic stem cell transplantation,allogeneic stem cell transplantation,treatment,20
donor lymphocyte infusion,donor lymphocyte infusion,treatment,20
hydroxyurea,hydroxyurea,treatment,5
omacetaxine,omacetaxine,treatment,20
interferon alfa-2c,interferon alfa-2c,treatment,20
bcr,bcr,gene,20
abl1,abl1,gene,20
bcr/abl1 fusion gene,bcr/abl1 fusion gene,cause,20
chronic phase,chronic phase,subtype,20
clear cell sarcoma,clear cell sarcoma,disease,3
ewsr1/atf1 fusion gene,ewsr1/atf1 fusion gene,cause,3
ewsr1/creb1 fusion gene,ewsr1/creb1 fusion gene,cause,3
ewsr1/ddit3 fusion gene,ewsr1/ddit3 fusion gene,cause,3
colorectal cancer,colorectal cancer,disease,4
apc,apc,gene,4
axin1,axin1,gene,14
axin2,axin2,gene,4
tcf7l2,tcf7l2,gene,4
nkd1,nkd1,gene,4
bax,bax,gene,4
dcc,dcc,gene,4
smad1,smad1,gene,4
pi3,pi3,gene,4
fam13b,fam13b,gene,4
sox9,sox9,gene,4
atm,atm,gene,7
arid1a,arid1a,gene,14
acvr2a,acvr2a,gene,4
tgfbr2,tgfbr2,gene,4
msh3,msh3,gene,4
slc9a9,slc9a9,gene,4
pole,pole,gene,4
pold1,pold1,gene,4
macc1,macc1,gene,4
hspa1a,hspa1a,gene,4
rbm3,rbm3,gene,4
screening test,screening test,diagnosis,4
colonoscopy,colonoscopy,diagnosis,4
apc gene mutation,apc gene mutation,cause,4
mismatch repair deficiency,mismatch repair deficiency,cause,4
personal history of colorectal cancer,personal history of colorectal cancer,risk_factor,4
colon cancer,colon cancer,subtype,4
rectum cancer,rectum cancer,subtype,4
lymphoma,lymphoma,subtype,10
hypermutated colorectal carcinoma,hypermutated colorectal carcinoma,subtype,4
cutaneous t-cell lymphoma,cutaneous t-cell lymphoma,disease,10
histone deacetylase inhibitor,histone deacetylase inhibitor,treatment,10
htlv-1 infection,htlv-1 infection,risk_factor,10
epstein-barr virus infectious disease,epstein-barr virus infectious disease,risk_factor,13
obsolete cytomegalovirus infectious disease,obsolete cytomegalovirus infectious disease,risk_factor,10
hhv6 infection,hhv6 infection,risk_factor,10
staphylococcus aureus infection,staphylococcus aureus infection,risk_factor,10
mycosis fungoides,mycosis fungoides,subtype,10
adult t-cell leukemia/lymphoma,adult t-cell leukemia/lymphoma,subtype,10
dermatofibrosarcoma protuberans (dfsp),dermatofibrosarcoma protuberans (dfsp),disease,2
wide local excision,wide local excision,treatment,2
col1a1,col1a1,gene,2
pdgfd,pdgfd,gene,2
cd34,cd34,gene,2
ovarian granulosa cell,ovarian granulosa cell,subtype,2
desmoid tumor,desmoid tumor,disease,4
nirogacestat,nirogacestat,treatment,4
nonsteroidal antiinflammatory drug,nonsteroidal antiinflammatory drug,treatment,4
familial adenomatous polyposis 1,familial adenomatous polyposis 1,cause,14
gardner syndrome,gardner syndrome,cause,4
pregnancy,pregnancy,cause,4
periosteal desmoid tumor,periosteal desmoid tumor,subtype,4
embryonal carcinoma,embryonal carcinoma,disease,22
thymus cancer,thymus cancer,disease,2
hormone therapy,hormone therapy,treatment,9
myasthenia gravis,myasthenia gravis,risk_factor,2
lupus erythematosus,lupus erythematosus,risk_factor,2
rheumatoid arthritis,rheumatoid arthritis,risk_factor,2
endometrial cancer,endometrial cancer,disease,9
progestin,progestin,treatment,9
hydroxyprogesterone caproate,hydroxyprogesterone caproate,treatment,9
letrozole,letrozole,treatment,9
megestrol acetate,megestrol acetate,treatment,9
medroxyprogesterone,medroxyprogesterone,treatment,9
paclitaxel,paclitaxel,treatment,9
docetaxel,docetaxel,treatment,9
spop,spop,gene,16
endometrial biopsy,endometrial biopsy,diagnosis,9
dilation and curettage,dilation and curettage,diagnosis,9
transvaginal ultrasound,transvaginal ultrasound,diagnosis,9
chromosomal instability,chromosomal instability,cause,9
kras gene mutation,kras gene mutation,cause,1
microsatellite instability,microsatellite instability,cause,9
endometrial hyperplasia,endometrial hyperplasia,cause,9
metabolic syndrome,metabolic syndrome,risk_factor,9
type 2 diabetes mellitus,type 2 diabetes mellitus,risk_factor,9
insulin resistance,insulin resistance,risk_factor,9
polycystic ovary syndrome,polycystic ovary syndrome,risk_factor,9
lynch syndrome,lynch syndrome,risk_factor,9
ovarian granulosa cell tumor,ovarian granulosa cell tumor,risk_factor,9
thecoma,thecoma,risk_factor,9
cowden syndrome,cowden syndrome,risk_factor,9
endometrial carcinoma,endometrial carcinoma,subtype,9
villoglandular endometrial endometrioid adenocarcinoma,villoglandular endometrial endometrioid adenocarcinoma,subtype,9
recurrent endometrioid adenocarcinoma,recurrent endometrioid adenocarcinoma,subtype,9
ovarian endometrioid adenocarcinoma with squamous differentiation,ovarian endometrioid adenocarcinoma with squamous differentiation,subtype,9
endometrial mucinous adenocarcinoma,endometrial mucinous adenocarcinoma,subtype,9
serous cystadenocarcinoma,serous cystadenocarcinoma,subtype,9
large cell carcinoma,large cell carcinoma,subtype,11
mixed carcinoma,mixed carcinoma,subtype,9
undifferentiated carcinoma,undifferentiated carcinoma,subtype,1
metastatic squamous cell carcinoma,metastatic squamous cell carcinoma,subtype,9
endometrial stromal sarcoma,endometrial stromal sarcoma,subtype,9
rat endometrial stromal sarcoma,rat endometrial stromal sarcoma,subtype,9
type i endometrial adenocarcinoma,type i endometrial adenocarcinoma,subtype,9
type ii endometrial adenocarcinoma,type ii endometrial adenocarcinoma,subtype,9
primitive neuroectodermal tumor,primitive neuroectodermal tumor,disease,20
adjuvant chemotherapy,adjuvant chemotherapy,treatment,1
ependymoma,ependymoma,disease,16
prophylactic cranial irradiation,prophylactic cranial irradiation,treatment,16
zfta,zfta,gene,16
yap1,yap1,gene,16
vestibular schwannomatosis,vestibular schwannomatosis,risk_factor,16
myxopapillary ependymoma,myxopapillary ependymoma,subtype,16
anaplastic ependymoma,anaplastic ependymoma,subtype,16
high grade ependymoma,high grade ependymoma,subtype,16
"embryonal tumor with multilayered rosettes, c19mc-altered","embryonal tumor with multilayered rosettes, c19mc-altered",subtype,16
mouse subependymoma,mouse subependymoma,subtype,16
supratentorial ependymoma,supratentorial ependymoma,subtype,16
spinal cord ependymoma,spinal cord ependymoma,subtype,16
epithelioid hemangioendothelioma,epithelioid hemangioendothelioma,disease,15
sorafenib,sorafenib,treatment,16
sunitinib,sunitinib,treatment,15
pazopanib,pazopanib,treatment,15
interferon,interferon,treatment,15
combination chemotherapy,combination chemotherapy,treatment,15
thalidomide,thalidomide,treatment,15
wwtr1,wwtr1,gene,15
camta1,camta1,gene,15
fos transcription factor family,fos transcription factor family,gene,15
cytogenetic analysis,cytogenetic analysis,diagnosis,15
esophageal cancer,esophageal cancer,disease,2
endoscopic mucosal resection,endoscopic mucosal resection,treatment,2
gastrostomy,gastrostomy,treatment,2
laser therapy,laser therapy,treatment,2
rhbdf2,rhbdf2,gene,2
hoxa13,hoxa13,gene,2
rai staging system,rai staging system,diagnosis,2
alcohol consumption,alcohol consumption,cause,13
nutritional deficiency,nutritional deficiency,cause,2
barrett's esophagus,barrett's esophagus,cause,2
achalasia,achalasia,cause,2
plummer-vinson syndrome,plummer-vinson syndrome,cause,2
dietary nitrosamine,dietary nitrosamine,risk_factor,2
gastroesophageal reflux disease,gastroesophageal reflux disease,risk_factor,2
bile reflux,bile reflux,risk_factor,2
human papillomavirus infection,human papillomavirus infection,risk_factor,2
head and neck cancer,head and neck cancer,risk_factor,13
palmoplantar keratoderma-esophageal carcinoma syndrome,palmoplantar keratoderma-esophageal carcinoma syndrome,risk_factor,2
esophageal adenocarcinoma,esophageal adenocarcinoma,subtype,2
leiomyosarcoma,leiomyosarcoma,subtype,2
rhabdomyosarcoma,rhabdomyosarcoma,subtype,8
nutritional support,nutritional support,treatment,2
antisense oligonucleotides,antisense oligonucleotides,treatment,21
proton beam radiation therapy,proton beam radiation therapy,treatment,21
ewsr1,ewsr1,gene,21
fli1,fli1,gene,21
egr2,egr2,gene,21
nkx2-2,nkx2-2,gene,21
cd99,cd99,gene,21
micu2,micu2,gene,21
morphologic finding,morphologic finding,diagnosis,21
magnetic resonance imaging,magnetic resonance imaging,diagnosis,21
ewsr1/fli1 fusion protein,ewsr1/fli1 fusion protein,cause,21
eye cancer,eye cancer,disease,2
general surgery,general surgery,treatment,2
retinoblastoma,retinoblastoma,subtype,8
malignant conjunctival melanoma,malignant conjunctival melanoma,subtype,2
orbit lymphoma,orbit lymphoma,subtype,2
fallopian tube cancer,fallopian tube cancer,disease,9
brca1 gene mutation,brca1 gene mutation,cause,9
brca2 gene mutation,brca2 gene mutation,cause,9
endometriosis,endometriosis,risk_factor,9
hormone replacement therapy,hormone replacement therapy,risk_factor,9
tall stature,tall stature,risk_factor,9
adult fibrosarcoma,adult fibrosarcoma,subtype,2
infantile fibrosarcoma,infantile fibrosarcoma,subtype,2
gallbladder cancer,gallbladder cancer,disease,10
percutaneous transhepatic biliary drainage,percutaneous transhepatic biliary drainage,treatment,10
transabdominal ultrasound,transabdominal ultrasound,diagnosis,10
endoscopic ultrasound,endoscopic ultrasound,diagnosis,10
gallbladder pain,gallbladder pain,cause,10
chronic cholecystitis,chronic cholecystitis,cause,10
female gender,female gender,risk_factor,10
gallbladder polyp,gallbladder polyp,risk_factor,10
gastric cancer,gastric cancer,disease,10
gene therapy,gene therapy,treatment,10
itgav,itgav,gene,10
dusp1,dusp1,gene,10
p2rx7,p2rx7,gene,10
breath test,breath test,diagnosis,10
optical coherence tomography,optical coherence tomography,diagnosis,10
fecal occult blood test,fecal occult blood test,diagnosis,10
helicobacter pylori infection,helicobacter pylori infection,cause,10
hereditary diffuse gastric cancer,hereditary diffuse gastric cancer,cause,10
iodine deficiency,iodine deficiency,risk_factor,10
acquired immunodeficiency syndrome,acquired immunodeficiency syndrome,risk_factor,10
gastric adenocarcinoma,gastric adenocarcinoma,subtype,10
mesenchymal cell neoplasm,mesenchymal cell neoplasm,subtype,10
intestinal-type adenocarcinoma,intestinal-type adenocarcinoma,subtype,10
diffuse type adenocarcinoma,diffuse type adenocarcinoma,subtype,10
signet ring cell carcinoma,signet ring cell carcinoma,subtype,10
diffuse large b-cell lymphoma,diffuse large b-cell lymphoma,subtype,10
obsolete stromal neoplasm,obsolete stromal neoplasm,subtype,10
stomach cancer,stomach cancer,disease,10
panendoscopy,panendoscopy,diagnosis,13
family history of stomach cancer,family history of stomach cancer,risk_factor,10
red meat consumption,red meat consumption,risk_factor,10
gastric carcinoma,gastric carcinoma,subtype,10
gestational trophoblastic disease,gestational trophoblastic disease,disease,11
ultrasound,ultrasound,diagnosis,11
histologic confirmation date,histologic confirmation date,diagnosis,11
complete hydatidiform mole,complete hydatidiform mole,subtype,11
partial hydatidiform mole,partial hydatidiform mole,subtype,11
placental site trophoblastic tumor,placental site trophoblastic tumor,subtype,11
epithelioid trophoblastic tumor,epithelioid trophoblastic tumor,subtype,11
gestational trophoblastic neoplasm,gestational trophoblastic neoplasm,subtype,11
supportive care,supportive care,treatment,20
cognitive behavior therapy,cognitive behavior therapy,treatment,5
yoga,yoga,treatment,5
medication,medication,treatment,5
nf1,nf1,gene,3
mgmt,mgmt,gene,5
pdgfra,pdgfra,gene,5
stat3,stat3,gene,5
cyp1b1-as1,cyp1b1-as1,gene,5
egfr gene amplification,egfr gene amplification,cause,5
mgmt gene promoter methylation,mgmt gene promoter methylation,cause,5
pesticide exposure,pesticide exposure,risk_factor,5
mesenchymal,mesenchymal,subtype,5
idh-wildtype glioblastoma,idh-wildtype glioblastoma,subtype,5
glomus tumor,glomus tumor,disease,12
solid glomus tumor,solid glomus tumor,subtype,12
glomangioma,glomangioma,subtype,12
glomangiomyoma,glomangiomyoma,subtype,12
malignant glomus tumor,malignant glomus tumor,subtype,12
granulosa cell tumour,granulosa cell tumour,disease,16
foxl2,foxl2,gene,16
adult granulosa cell tumor,adult granulosa cell tumor,subtype,16
juvenile type testicular granulosa cell tumor,juvenile type testicular granulosa cell tumor,subtype,16
hairy cell leukemia,hairy cell leukemia,disease,5
cancer immunotherapy,cancer immunotherapy,treatment,13
rehabilitation,rehabilitation,treatment,13
physical therapy,physical therapy,treatment,13
speech therapist,speech therapist,treatment,13
maxillectomy,maxillectomy,treatment,13
mandibulectomy,mandibulectomy,treatment,13
glossectomy,glossectomy,treatment,13
radical neck dissection,radical neck dissection,treatment,13
partial laryngectomy,partial laryngectomy,treatment,13
total laryngectomy,total laryngectomy,treatment,13
esophageal speech,esophageal speech,treatment,13
tracheoesophageal puncture,tracheoesophageal puncture,treatment,13
electrolarynx,electrolarynx,treatment,13
intensity-modulated radiation therapy,intensity-modulated radiation therapy,treatment,13
cetuximab,cetuximab,treatment,4
fluorouracil,fluorouracil,treatment,4
amifostine,amifostine,treatment,13
bevacizumab,bevacizumab,treatment,4
checkpoint blockade immunotherapy,checkpoint blockade immunotherapy,treatment,13
nivolumab,nivolumab,treatment,13
transoral robotic surgery,transoral robotic surgery,treatment,13
transoral laser microsurgery,transoral laser microsurgery,treatment,13
prb1,prb1,gene,13
alcohol dehydrogenases,alcohol dehydrogenases,gene,13
chest computed tomography,chest computed tomography,diagnosis,14
tobacco use,tobacco use,cause,13
wood dust exposure,wood dust exposure,cause,13
hpv16 infection,hpv16 infection,risk_factor,13
age greater than 85 years,age greater than 85 years,risk_factor,13
socioeconomic factors,socioeconomic factors,risk_factor,13
leukoplakia,leukoplakia,risk_factor,13
allogeneic hematopoietic stem cell transplantation,allogeneic hematopoietic stem cell transplantation,risk_factor,13
orbital cancer,orbital cancer,subtype,13
pharynx cancer,pharynx cancer,subtype,13
oropharynx cancer,oropharynx cancer,subtype,13
hypopharynx cancer,hypopharynx cancer,subtype,13
salivary gland cancer,salivary gland cancer,subtype,11
glottis cancer,glottis cancer,subtype,13
supraglottis cancer,supraglottis cancer,subtype,13
subglottis cancer,subglottis cancer,subtype,13
hepatoblastoma,hepatoblastoma,disease,14
beckwith-wiedemann syndrome,beckwith-wiedemann syndrome,risk_factor,14
trisomy 18,trisomy 18,risk_factor,14
trisomy 21,trisomy 21,risk_factor,14
aicardi syndrome,aicardi syndrome,risk_factor,14
li-fraumeni syndrome,li-fraumeni syndrome,risk_factor,14
goldenhar syndrome,goldenhar syndrome,risk_factor,14
glycogen storage disease i,glycogen storage disease i,risk_factor,14
hepatocellular carcinoma,hepatocellular carcinoma,disease,14
radiofrequency ablation,radiofrequency ablation,treatment,14
selective internal radiation therapy,selective internal radiation therapy,treatment,3
systemic therapy,systemic therapy,treatment,14
arid2,arid2,gene,14
abcb11,abcb11,gene,14
des-gamma carboxyprothrombin,des-gamma carboxyprothrombin,diagnosis,14
mri without contrast,mri without contrast,diagnosis,14
pet scan without contrast,pet scan without contrast,diagnosis,14
chronic liver disease,chronic liver disease,cause,14
fibrosis,fibrosis,cause,14
inflammation,inflammation,cause,14
nonalcoholic steatohepatitis,nonalcoholic steatohepatitis,cause,14
hemochromatosis,hemochromatosis,cause,14
alpha 1-antitrypsin deficiency,alpha 1-antitrypsin deficiency,cause,14
biliary atresia,biliary atresia,cause,14
glycogen storage disease,glycogen storage disease,cause,14
nonalcoholic fatty liver disease,nonalcoholic fatty liver disease,risk_factor,14
congenital lens disorder,congenital lens disorder,risk_factor,14
fibrolamellar carcinoma,fibrolamellar carcinoma,risk_factor,14
alcohol use disorder,alcohol use disorder,risk_factor,14
clear cell,clear cell,subtype,17
hodgkin lymphoma,hodgkin lymphoma,disease,13
brentuximab vedotin,brentuximab vedotin,treatment,13
unknown,unknown,cause,13
classic hodgkin lymphoma,classic hodgkin lymphoma,subtype,13
multiple sclerosis,multiple sclerosis,subtype,13
hypopharyngeal cancer,hypopharyngeal cancer,disease,2
parp1,parp1,gene,2
chewing tobacco,chewing tobacco,cause,2
inflammatory breast cancer,inflammatory breast cancer,disease,16
vegfa,vegfa,gene,16
mammogram,mammogram,diagnosis,16
biopsy of breast,biopsy of breast,diagnosis,16
endoscopic submucosal dissection,endoscopic submucosal dissection,treatment,4
partial colectomy,partial colectomy,treatment,4
proctocolectomy,proctocolectomy,treatment,4
colostomy,colostomy,treatment,4
oxaliplatin,oxaliplatin,treatment,4
panitumumab,panitumumab,treatment,4
chemoradiotherapy,chemoradiotherapy,treatment,11
dostarlimab,dostarlimab,treatment,4
aspirin,aspirin,treatment,4
celecoxib,celecoxib,treatment,4
sigmoidoscopy,sigmoidoscopy,diagnosis,4
fecal immunochemical test,fecal immunochemical test,diagnosis,4
axin1 gene mutation,axin1 gene mutation,cause,4
axin2 gene mutation,axin2 gene mutation,cause,4
tcf7l2 gene mutation,tcf7l2 gene mutation,cause,4
pten gene mutation,pten gene mutation,cause,4
sox9 gene mutation,sox9 gene mutation,cause,4
arid1a gene mutation,arid1a gene mutation,cause,4
msh3 gene mutation,msh3 gene mutation,cause,4
msh6 gene mutation,msh6 gene mutation,cause,4
braf gene mutation,braf gene mutation,cause,4
mismatch repair protein deficiency,mismatch repair protein deficiency,cause,4
pole gene mutation,pole gene mutation,cause,4
pold1 gene mutation,pold1 gene mutation,cause,4
clostridium,clostridium,cause,4
escherichia coli,escherichia coli,cause,4
fusobacterium nucleatum,fusobacterium nucleatum,cause,4
crohn's disease,crohn's disease,risk_factor,4
celiac disease,celiac disease,risk_factor,4
inflammatory bowel disease,inflammatory bowel disease,risk_factor,4
prolonged standing,prolonged standing,risk_factor,9
vitamin d deficiency,vitamin d deficiency,risk_factor,4
bile duct cancer,bile duct cancer,disease,2
invasive ductal carcinoma,invasive ductal carcinoma,disease,16
neoadjuvant therapy,neoadjuvant therapy,treatment,16
prophylactic mastectomy,prophylactic mastectomy,treatment,16
pleomorphic carcinoma,pleomorphic carcinoma,subtype,16
breast carcinoma with osteoclast-like stromal giant cells,breast carcinoma with osteoclast-like stromal giant cells,subtype,16
breast carcinoma with choriocarcinomatous features,breast carcinoma with choriocarcinomatous features,subtype,16
breast carcinoma with melanotic features,breast carcinoma with melanotic features,subtype,16
cribriform carcinoma,cribriform carcinoma,subtype,16
kaposi sarcoma,kaposi sarcoma,disease,8
interferon alpha,interferon alpha,treatment,8
organ transplantation,organ transplantation,risk_factor,8
blood transfusion,blood transfusion,risk_factor,8
classic kaposi sarcoma,classic kaposi sarcoma,subtype,8
obsolete aids-related kaposi's sarcoma,obsolete aids-related kaposi's sarcoma,subtype,8
kaposi's sarcoma,kaposi's sarcoma,subtype,8
kidney cancer,kidney cancer,disease,15
everolimus,everolimus,treatment,15
axitinib,axitinib,treatment,15
cabozantinib,cabozantinib,treatment,15
comprehensive metabolic panel,comprehensive metabolic panel,diagnosis,15
urinalysis,urinalysis,diagnosis,15
aging,aging,risk_factor,15
family history of kidney cancer,family history of kidney cancer,risk_factor,15
nephroblastoma,nephroblastoma,subtype,15
collecting duct carcinoma,collecting duct carcinoma,subtype,15
renal cell carcinoma associated with neuroblastoma,renal cell carcinoma associated with neuroblastoma,subtype,15
mucinous tubular and spindle renal cell carcinoma,mucinous tubular and spindle renal cell carcinoma,subtype,15
mixed epithelial stromal tumour,mixed epithelial stromal tumour,subtype,15
laryngeal cancer,laryngeal cancer,disease,13
occupational therapy,occupational therapy,treatment,13
psychosocial care,psychosocial care,treatment,13
dental care,dental care,treatment,13
genomic instability,genomic instability,cause,2
uterus leiomyosarcoma,uterus leiomyosarcoma,subtype,2
cutaneous leiomyosarcoma,cutaneous leiomyosarcoma,subtype,2
retroperitoneal leiomyosarcoma,retroperitoneal leiomyosarcoma,subtype,2
rectal leiomyosarcoma,rectal leiomyosarcoma,subtype,2
leukemia,leukemia,disease,20
chlorambucil,chlorambucil,treatment,20
cyclophosphamide,cyclophosphamide,treatment,15
splenectomy,splenectomy,treatment,20
spred1,spred1,gene,20
formaldehyde exposure,formaldehyde exposure,cause,20
maternal transmission,maternal transmission,cause,20
prior chemotherapy,prior chemotherapy,risk_factor,20
down syndrome,down syndrome,risk_factor,20
fanconi anemia,fanconi anemia,risk_factor,20
family history of leukemia,family history of leukemia,risk_factor,20
acute lymphoblastic leukemia,acute lymphoblastic leukemia,subtype,10
acute myeloid leukemia,acute myeloid leukemia,subtype,10
t-cell prolymphocytic leukemia,t-cell prolymphocytic leukemia,subtype,20
t-cell large granular lymphocyte leukemia,t-cell large granular lymphocyte leukemia,subtype,20
juvenile myelomonocytic leukemia,juvenile myelomonocytic leukemia,subtype,20
acute promyelocytic leukemia,acute promyelocytic leukemia,subtype,20
acute megakaryoblastic leukemia,acute megakaryoblastic leukemia,subtype,20
b-cell prolymphocytic leukemia,b-cell prolymphocytic leukemia,subtype,20
chronic myelomonocytic leukemia,chronic myelomonocytic leukemia,subtype,20
burkitt leukemia,burkitt leukemia,subtype,20
acute biphenotypic leukemia,acute biphenotypic leukemia,subtype,20
recurrent b acute lymphoblastic leukemia,recurrent b acute lymphoblastic leukemia,subtype,20
t-cell adult acute lymphocytic leukemia,t-cell adult acute lymphocytic leukemia,subtype,20
liposarcoma,liposarcoma,disease,21
mdm2,mdm2,gene,1
cdk4,cdk4,gene,21
tspan31,tspan31,gene,21
hmga2,hmga2,gene,21
jun,jun,gene,21
ptk2b,ptk2b,gene,21
epha5,epha5,gene,21
erbb4,erbb4,gene,21
rp1,rp1,gene,21
rcbtb2,rcbtb2,gene,21
dleu1,dleu1,gene,21
itm2b,itm2b,gene,21
mtor,mtor,gene,21
dedifferentiated liposarcoma,dedifferentiated liposarcoma,subtype,21
myxoid liposarcoma,myxoid liposarcoma,subtype,21
pleomorphic liposarcoma,pleomorphic liposarcoma,subtype,21
myxoid pleomorphic liposarcoma,myxoid pleomorphic liposarcoma,subtype,21
liver cancer,liver cancer,disease,14
chimeric antigen receptor t-cell therapy,chimeric antigen receptor t-cell therapy,treatment,14
liver biopsy,liver biopsy,diagnosis,14
endoscopic retrograde cholangiopancreatography,endoscopic retrograde cholangiopancreatography,diagnosis,14
fascioliasis,fascioliasis,cause,14
hereditary hemochromatosis,hereditary hemochromatosis,cause,14
primary biliary cirrhosis,primary biliary cirrhosis,cause,14
opisthorchis viverrini infection,opisthorchis viverrini infection,cause,14
sclerosing cholangitis,sclerosing cholangitis,cause,14
choledochal cyst,choledochal cyst,cause,14
caroli disease,caroli disease,cause,14
congenital hepatic fibrosis,congenital hepatic fibrosis,cause,14
alpha-1 antitrypsin deficiency,alpha-1 antitrypsin deficiency,cause,14
porphyria cutanea tarda,porphyria cutanea tarda,cause,14
wilson disease,wilson disease,cause,14
tyrosinemia,tyrosinemia,cause,14
radiation exposure,radiation exposure,cause,7
familial adenomatous polyposis,familial adenomatous polyposis,risk_factor,14
low birth weight,low birth weight,risk_factor,14
progressive familial intrahepatic cholestasis,progressive familial intrahepatic cholestasis,risk_factor,14
liver embryonal sarcoma,liver embryonal sarcoma,subtype,14
bladder rhabdomyosarcoma,bladder rhabdomyosarcoma,subtype,14
lung cancer,lung cancer,disease,18
topotecan,topotecan,treatment,18
lurbinectedin,lurbinectedin,treatment,18
vinorelbine,vinorelbine,treatment,18
osimertinib,osimertinib,treatment,18
gefitinib,gefitinib,treatment,18
dacomitinib,dacomitinib,treatment,18
crizotinib,crizotinib,treatment,18
alectinib,alectinib,treatment,18
brigatinib,brigatinib,treatment,18
ceritinib,ceritinib,treatment,18
lorlatinib,lorlatinib,treatment,18
capmatinib,capmatinib,treatment,18
tepotinib,tepotinib,treatment,18
dabrafenib,dabrafenib,treatment,18
trametinib,trametinib,treatment,18
entrectinib,entrectinib,treatment,18
larotrectinib,larotrectinib,treatment,18
selpercatinib,selpercatinib,treatment,18
atezolizumab,atezolizumab,treatment,18
ipilimumab,ipilimumab,treatment,18
ramucirumab,ramucirumab,treatment,18
bronchoscopy,bronchoscopy,treatment,18
antibiotic,antibiotic,treatment,18
diuretic,diuretic,treatment,18
benzodiazepine,benzodiazepine,treatment,18
acetaminophen,acetaminophen,treatment,18
tricyclic antidepressant,tricyclic antidepressant,treatment,18
segmentectomy,segmentectomy,treatment,18
pneumonectomy,pneumonectomy,treatment,18
stereotactic body radiation therapy,stereotactic body radiation therapy,treatment,18
video-assisted thoracic surgery,video-assisted thoracic surgery,treatment,18
alk,alk,gene,18
met,met,gene,18
ros1,ros1,gene,18
ntrk1,ntrk1,gene,18
ret,ret,gene,1
liquid biopsy,liquid biopsy,diagnosis,18
asbestos exposure,asbestos exposure,cause,2
chromium exposure,chromium exposure,cause,18
scleroderma,scleroderma,cause,18
tuberculosis,tuberculosis,cause,18
human papillomavirus,human papillomavirus,cause,18
bk virus,bk virus,cause,18
jc virus,jc virus,cause,18
cytomegalovirus mrna,cytomegalovirus mrna,cause,18
sv40,sv40,cause,18
egfr gene mutation,egfr gene mutation,cause,18
alk gene mutation,alk gene mutation,cause,18
met gene mutation,met gene mutation,cause,18
pik3ca gene mutation,pik3ca gene mutation,cause,18
ros1 gene mutation,ros1 gene mutation,cause,18
ntrk1 gene mutation,ntrk1 gene mutation,cause,18
ret gene mutation,ret gene mutation,cause,18
occupational exposure,occupational exposure,risk_factor,18
vaping,vaping,risk_factor,18
unit of exposure to ionizing radiation,unit of exposure to ionizing radiation,risk_factor,5
diesel exhaust exposure,diesel exhaust exposure,risk_factor,18
lung non-small cell carcinoma,lung non-small cell carcinoma,subtype,18
sarcomatoid carcinoma,sarcomatoid carcinoma,subtype,18
lepidic adenocarcinoma,lepidic adenocarcinoma,subtype,18
lung acinar adenocarcinoma,lung acinar adenocarcinoma,subtype,18
papillary adenocarcinoma,papillary adenocarcinoma,subtype,18
lung micropapillary adenocarcinoma,lung micropapillary adenocarcinoma,subtype,18
extensive stage,extensive stage,subtype,18
pancoast tumor,pancoast tumor,subtype,18
lymphangiosarcoma,lymphangiosarcoma,disease,9
primary lymphedema,primary lymphedema,risk_factor,9
secondary lymphedema,secondary lymphedema,risk_factor,9
platelet transfusion,platelet transfusion,treatment,10
immunophenotype,immunophenotype,diagnosis,10
flow cytometry,flow cytometry,diagnosis,10
fluorescence in situ hybridization,fluorescence in situ hybridization,diagnosis,5
autoimmune disease,autoimmune disease,risk_factor,10
hodgkin's lymphoma,hodgkin's lymphoma,subtype,10
non-hodgkin lymphoma,non-hodgkin lymphoma,subtype,10
burkitt lymphoma,burkitt lymphoma,subtype,10
"diffuse large b-cell lymphoma, not otherwise specified","diffuse large b-cell lymphoma, not otherwise specified",subtype,10
diffuse large b-cell lymphoma associated with chronic inflammation,diffuse large b-cell lymphoma associated with chronic inflammation,subtype,10
fibrin-associated diffuse large b-cell lymphoma,fibrin-associated diffuse large b-cell lymphoma,subtype,10
primary effusion lymphoma,primary effusion lymphoma,subtype,10
plasmablastic lymphoma,plasmablastic lymphoma,subtype,10
nasal type extranodal nk/t-cell lymphoma,nasal type extranodal nk/t-cell lymphoma,subtype,10
"peripheral t-cell lymphoma, not otherwise specified","peripheral t-cell lymphoma, not otherwise specified",subtype,10
angioimmunoblastic t-cell lymphoma,angioimmunoblastic t-cell lymphoma,subtype,10
small lymphocytic lymphoma,small lymphocytic lymphoma,subtype,10
follicular lymphoma,follicular lymphoma,subtype,10
mantle cell lymphoma,mantle cell lymphoma,subtype,10
enteropathy-associated t-cell lymphoma,enteropathy-associated t-cell lymphoma,subtype,10
male breast cancer,male breast cancer,disease,16
aromatase inhibitor,aromatase inhibitor,treatment,16
chek2,chek2,gene,16
rad51d,rad51d,gene,16
epcam,epcam,gene,16
mammography,mammography,diagnosis,16
ultrasonogram,ultrasonogram,diagnosis,16
scintimammography,scintimammography,diagnosis,16
incisional biopsy,incisional biopsy,diagnosis,16
excisional biopsy,excisional biopsy,diagnosis,16
progesterone receptor test,progesterone receptor test,diagnosis,16
liver cirrhosis,liver cirrhosis,risk_factor,16
ventricular dysfunction,ventricular dysfunction,risk_factor,16
physical activity level,physical activity level,risk_factor,16
breast medullary carcinoma,breast medullary carcinoma,subtype,16
inflammatory breast carcinoma,inflammatory breast carcinoma,subtype,16
phyllodes tumor,phyllodes tumor,subtype,16
breast leiomyosarcoma,breast leiomyosarcoma,subtype,16
mammary analogue secretory carcinoma,mammary analogue secretory carcinoma,subtype,16
invasive breast cribriform carcinoma,invasive breast cribriform carcinoma,subtype,16
breast tubular carcinoma,breast tubular carcinoma,subtype,16
malignant melanoma of the eye,malignant melanoma of the eye,disease,2
art therapy,art therapy,treatment,2
malignant mesothelioma,malignant mesothelioma,disease,17
bap1,bap1,gene,17
axl,axl,gene,17
thoracoscopy,thoracoscopy,diagnosis,17
thoracotomy,thoracotomy,diagnosis,17
laparoscopy,laparoscopy,diagnosis,17
genetics,genetics,risk_factor,20
epithelioid mesothelioma,epithelioid mesothelioma,subtype,17
sarcomatoid mesothelioma,sarcomatoid mesothelioma,subtype,17
biphasic mesothelioma,biphasic mesothelioma,subtype,17
desmoplastic,desmoplastic,subtype,17
benign pleural mesothelioma,benign pleural mesothelioma,subtype,17
peritoneal mesothelioma,peritoneal mesothelioma,subtype,17
pericardial mesothelioma,pericardial mesothelioma,subtype,17
malignant mixed müllerian tumor,malignant mixed müllerian tumor,disease,16
endometrioid adenocarcinoma,endometrioid adenocarcinoma,subtype,16
serous adenocarcinoma,serous adenocarcinoma,subtype,16
clear cell adenocarcinoma,clear cell adenocarcinoma,subtype,16
malignant peripheral nerve sheath tumor,malignant peripheral nerve sheath tumor,disease,3
chromosome 11 loss of heterozygosity,chromosome 11 loss of heterozygosity,cause,3
neurofibromatosis type 1,neurofibromatosis type 1,risk_factor,3
malignant rhabdoid tumor,malignant rhabdoid tumor,disease,2
mediastinal germ cell tumor,mediastinal germ cell tumor,disease,22
seminoma,seminoma,subtype,22
nongerminomatous germ cell tumor,nongerminomatous germ cell tumor,subtype,22
medullary thyroid cancer,medullary thyroid cancer,disease,2
familial medullary thyroid carcinoma,familial medullary thyroid carcinoma,subtype,2
lomustine,lomustine,treatment,15
smarca4,smarca4,gene,15
ddx3x,ddx3x,gene,15
ctdnep1,ctdnep1,gene,15
kdm6a,kdm6a,gene,15
tbr1,tbr1,gene,15
mycn,mycn,gene,8
gli2,gli2,gene,15
sufu,sufu,gene,15
cxcl3,cxcl3,gene,15
evans staging system,evans staging system,diagnosis,15
smarca4 gene mutation,smarca4 gene mutation,cause,15
ddx3x gene mutation,ddx3x gene mutation,cause,15
kdm6a gene mutation,kdm6a gene mutation,cause,15
nevoid basal cell carcinoma syndrome,nevoid basal cell carcinoma syndrome,risk_factor,15
turcot syndrome,turcot syndrome,risk_factor,15
obsolete group b streptococcal pneumonia,obsolete group b streptococcal pneumonia,subtype,15
talimogene laherparepvec,talimogene laherparepvec,treatment,18
mc1r,mc1r,gene,18
raf1,raf1,gene,18
ntrk3,ntrk3,gene,18
igf1r,igf1r,gene,18
mcm6,mcm6,gene,18
timeless,timeless,gene,18
wipi1,wipi1,gene,18
dermoscopy,dermoscopy,diagnosis,18
reflectance confocal microscopy,reflectance confocal microscopy,diagnosis,18
xeroderma pigmentosum,xeroderma pigmentosum,risk_factor,18
large congenital melanocytic nevus,large congenital melanocytic nevus,risk_factor,18
nodular malignant melanoma,nodular malignant melanoma,subtype,18
amelanotic melanoma,amelanotic melanoma,subtype,8
anal melanoma,anal melanoma,subtype,18
mucosal melanoma,mucosal melanoma,subtype,18
desmoplastic melanoma,desmoplastic melanoma,subtype,18
uveal melanoma,uveal melanoma,subtype,18
vaginal melanoma,vaginal melanoma,subtype,18
lentigo maligna melanoma,lentigo maligna melanoma,subtype,18
acral lentiginous melanoma,acral lentiginous melanoma,subtype,18
radiosurgery,radiosurgery,treatment,5
traf7,traf7,gene,5
klf4,klf4,gene,5
arteriography,arteriography,diagnosis,5
medical image,medical image,diagnosis,5
brain injury,brain injury,cause,5
neurofibromatosis type 2,neurofibromatosis type 2,cause,5
transition,transition,subtype,5
angioblast,angioblast,subtype,5
choroid,choroid,subtype,5
papillary,papillary,subtype,5
merkel cell carcinoma,merkel cell carcinoma,disease,8
piezo2,piezo2,gene,8
atoh1,atoh1,gene,8
merkel cell polyomavirus,merkel cell polyomavirus,cause,8
mesothelioma,mesothelioma,disease,17
thoracentesis,thoracentesis,diagnosis,17
tube thoracostomy,tube thoracostomy,diagnosis,17
paracentesis,paracentesis,diagnosis,17
pericardiocentesis,pericardiocentesis,diagnosis,17
mucinous carcinoma,mucinous carcinoma,disease,19
ovarian mucinous tumor,ovarian mucinous tumor,subtype,19
colorectal mucinous adenocarcinoma,colorectal mucinous adenocarcinoma,subtype,19
mucinous ovarian tumor,mucinous ovarian tumor,disease,9
mucinous cystadenocarcinoma,mucinous cystadenocarcinoma,subtype,9
multiple endocrine neoplasia,multiple endocrine neoplasia,disease,1
autosomal dominant inheritance,autosomal dominant inheritance,risk_factor,1
multiple endocrine neoplasia type 1,multiple endocrine neoplasia type 1,subtype,1
multiple endocrine neoplasia type 2a,multiple endocrine neoplasia type 2a,subtype,1
multiple endocrine neoplasia type 2b,multiple endocrine neoplasia type 2b,subtype,1
biphosphonate,biphosphonate,treatment,7
ccnd1,ccnd1,gene,1
dis3,dis3,gene,7
fam246c,fam246c,gene,7
nras,nras,gene,7
ezh2,ezh2,gene,7
cytogenetics,cytogenetics,diagnosis,7
monoclonal gammopathy of undetermined significance,monoclonal gammopathy of undetermined significance,risk_factor,7
smoldering multiple myeloma,smoldering multiple myeloma,risk_factor,7
solitary plasmacytoma,solitary plasmacytoma,subtype,7
plasma cell leukemia,plasma cell leukemia,subtype,7
non-secretory myeloma,non-secretory myeloma,subtype,7
myelodysplastic syndromes,myelodysplastic syndromes,disease,20
lenalidomide,lenalidomide,treatment,20
anti-thymocyte globulin,anti-thymocyte globulin,treatment,20
luspatercept,luspatercept,treatment,20
gata2,gata2,gene,20
samd9,samd9,gene,20
samd9l,samd9l,gene,20
flt3,flt3,gene,20
sf3b1,sf3b1,gene,20
cebpa,cebpa,gene,20
ddx41,ddx41,gene,20
runx1,runx1,gene,20
gata2 deficiency,gata2 deficiency,cause,20
dna damage,dna damage,cause,20
clonal cytopenia of undetermined significance,clonal cytopenia of undetermined significance,subtype,20
chromosome 18q deletion syndrome,chromosome 18q deletion syndrome,subtype,20
refractory anemia,refractory anemia,subtype,20
myelofibrosis,myelofibrosis,disease,20
folic acid,folic acid,treatment,20
allopurinol,allopurinol,treatment,20
dexamethasone,dexamethasone,treatment,20
interferon alpha-2,interferon alpha-2,treatment,20
jak2,jak2,gene,20
calr,calr,gene,20
mpl,mpl,gene,20
reticulocyte count,reticulocyte count,diagnosis,20
environmental risk factor,environmental risk factor,cause,9
overt primary myelofibrosis,overt primary myelofibrosis,subtype,20
myxofibrosarcoma,myxofibrosarcoma,disease,1
angiogenesis inhibitor,angiogenesis inhibitor,treatment,1
cdkn2b,cdkn2b,gene,1
cdk6,cdk6,gene,1
epithelioid myxofibrosarcoma,epithelioid myxofibrosarcoma,subtype,1
nasal cavity and paranasal sinus cancer,nasal cavity and paranasal sinus cancer,disease,2
nasal cavity cancer,nasal cavity cancer,disease,2
tradition,tradition,treatment,7
nasopharyngeal carcinoma,nasopharyngeal carcinoma,disease,13
genetic susceptibility,genetic susceptibility,cause,13
keratinizing squamous cell carcinoma,keratinizing squamous cell carcinoma,subtype,13
basaloid squamous cell carcinoma,basaloid squamous cell carcinoma,subtype,13
wilms tumor,wilms tumor,disease,8
actinomycin f1,actinomycin f1,treatment,8
wt1,wt1,gene,9
wnt2,wnt2,gene,8
congenital abnormality,congenital abnormality,cause,8
wt1 gene mutation,wt1 gene mutation,cause,8
aniridia,aniridia,risk_factor,8
denys-drash syndrome,denys-drash syndrome,risk_factor,8
hemihypertrophy,hemihypertrophy,risk_factor,8
perlman syndrome,perlman syndrome,risk_factor,8
obsolete anaplastic renal wilms' tumor,obsolete anaplastic renal wilms' tumor,subtype,8
naxitamab,naxitamab,treatment,2
granulocyte-macrophage colony-stimulating factor,granulocyte-macrophage colony-stimulating factor,treatment,2
phox2b,phox2b,gene,2
kif1b,kif1b,gene,2
lmo1,lmo1,gene,2
ahcy,ahcy,gene,2
dpysl3,dpysl3,gene,2
nme1,nme1,gene,2
nbpf1,nbpf1,gene,2
bone marrow aspiration and biopsy,bone marrow aspiration and biopsy,diagnosis,2
surgical pathology,surgical pathology,diagnosis,2
immunohistochemical test,immunohistochemical test,diagnosis,2
international neuroblastoma staging system,international neuroblastoma staging system,diagnosis,2
international neuroblastoma risk group staging system,international neuroblastoma risk group staging system,diagnosis,2
atopy,atopy,risk_factor,2
ganglioneuroma,ganglioneuroma,subtype,2
ganglioneuroblastoma,ganglioneuroblastoma,subtype,2
neuroendocrine tumors,neuroendocrine tumors,disease,3
cholecystectomy,cholecystectomy,treatment,3
peptide receptor radionuclide therapy,peptide receptor radionuclide therapy,treatment,3
hepatic artery embolization,hepatic artery embolization,treatment,3
en2,en2,gene,3
vhl,vhl,gene,3
cdx2,cdx2,gene,3
neuroendocrine secretory protein 55,neuroendocrine secretory protein 55,diagnosis,3
mrs,mrs,diagnosis,3
pancreatic neuroendocrine tumor,pancreatic neuroendocrine tumor,subtype,3
paraganglioma,paraganglioma,subtype,3
merkel cell carcinoma of anal skin,merkel cell carcinoma of anal skin,subtype,3
medullary thyroid carcinoma,medullary thyroid carcinoma,subtype,3
thymic neuroendocrine tumor,thymic neuroendocrine tumor,subtype,3
pulmonary neuroendocrine tumor,pulmonary neuroendocrine tumor,subtype,3
breast neuroendocrine neoplasm,breast neuroendocrine neoplasm,subtype,3
peripheral nervous system,peripheral nervous system,subtype,3
schwannoma,schwannoma,subtype,3
plasmapheresis,plasmapheresis,treatment,10
mesenchymal stromal cell,mesenchymal stromal cell,treatment,10
follicular dendritic cell sarcoma,follicular dendritic cell sarcoma,subtype,10
gastric lymphoma,gastric lymphoma,subtype,10
splenic marginal zone lymphoma,splenic marginal zone lymphoma,subtype,10
lymphoplasmacytic lymphoma,lymphoplasmacytic lymphoma,subtype,10
skin cancer,skin cancer,disease,8
cryotherapy,cryotherapy,treatment,8
vaccine therapy,vaccine therapy,treatment,8
reconstructive surgery,reconstructive surgery,treatment,8
skin graft,skin graft,treatment,8
photography,photography,diagnosis,8
dermatoscope,dermatoscope,diagnosis,8
sonographer,sonographer,diagnosis,8
confocal microscopy,confocal microscopy,diagnosis,8
raman spectroscopy,raman spectroscopy,diagnosis,8
fluorescence spectroscopy,fluorescence spectroscopy,diagnosis,8
multispectral imaging,multispectral imaging,diagnosis,8
thermography,thermography,diagnosis,8
environmental carcinogen,environmental carcinogen,cause,8
atypical fibroxanthoma,atypical fibroxanthoma,subtype,8
porocarcinoma,porocarcinoma,subtype,8
sebaceous carcinoma,sebaceous carcinoma,subtype,8
microcystic adnexal carcinoma,microcystic adnexal carcinoma,subtype,8
keratoacanthoma,keratoacanthoma,subtype,8
skin sarcoma,skin sarcoma,subtype,8
dermatofibrosarcoma protuberans,dermatofibrosarcoma protuberans,subtype,8
olig2,olig2,gene,5
biopsy of brain,biopsy of brain,diagnosis,5
molecular diagnosis,molecular diagnosis,diagnosis,5
loss of heterozygosity analysis,loss of heterozygosity analysis,diagnosis,5
oral cancer,oral cancer,disease,13
acetaldehyde,acetaldehyde,cause,13
oral cavity cancer,oral cavity cancer,subtype,13
tongue cancer,tongue cancer,subtype,13
lip cancer,lip cancer,subtype,13
oropharyngeal cancer,oropharyngeal cancer,disease,2
stage r1,stage r1,subtype,2
stage r2,stage r2,subtype,2
stage m3,stage m3,subtype,2
stage a,stage a,subtype,2
stage b,stage b,subtype,2
stage c,stage c,subtype,2
salvage surgery,salvage surgery,treatment,16
rotationplasty,rotationplasty,treatment,16
setd2,setd2,gene,16
giant rod chromosome,giant rod chromosome,cause,16
rothmund-thomson syndrome,rothmund-thomson syndrome,cause,16
secondary,secondary,subtype,16
extraskeletal,extraskeletal,subtype,16
ovarian cancer,ovarian cancer,disease,9
interval debulking surgery,interval debulking surgery,treatment,9
laparoscopic surgery,laparoscopic surgery,treatment,9
laparotomy,laparotomy,treatment,9
bilateral salpingectomy,bilateral salpingectomy,treatment,9
omentectomy,omentectomy,treatment,9
posterior pelvic exenteration,posterior pelvic exenteration,treatment,9
lymphadenectomy,lymphadenectomy,treatment,9
intraperitoneal chemotherapy,intraperitoneal chemotherapy,treatment,9
cdk12,cdk12,gene,9
pms1,pms1,gene,9
esr2,esr2,gene,9
brip1,brip1,gene,9
rad51c,rad51c,gene,9
rad50,rad50,gene,9
kit,kit,gene,2
foxm1,foxm1,gene,9
retinal examination,retinal examination,diagnosis,9
body mass index,body mass index,risk_factor,9
ovary epithelial cancer,ovary epithelial cancer,subtype,9
malignant germ cell tumor,malignant germ cell tumor,subtype,9
serous tubal intraepithelial carcinoma,serous tubal intraepithelial carcinoma,subtype,9
adenocarcinoma cell,adenocarcinoma cell,subtype,9
pseudomyxoma peritonei,pseudomyxoma peritonei,subtype,9
esophageal undifferentiated carcinoma,esophageal undifferentiated carcinoma,subtype,9
sex cord-stromal tumor,sex cord-stromal tumor,subtype,22
juvenile granulosa cell tumor,juvenile granulosa cell tumor,subtype,9
fibroma,fibroma,subtype,9
germ cell tumor,germ cell tumor,subtype,9
dysgerminoma,dysgerminoma,subtype,9
mixed cell type cancer,mixed cell type cancer,subtype,9
ovarian germ cell tumors,ovarian germ cell tumors,disease,9
pelvic examination,pelvic examination,diagnosis,9
biopsy of soft tissue,biopsy of soft tissue,diagnosis,9
hereditary nonpolyposis colorectal cancer syndrome,hereditary nonpolyposis colorectal cancer syndrome,cause,9
pancreatic cancer,pancreatic cancer,disease,1
pain management,pain management,treatment,1
smad4,smad4,gene,1
stk11,stk11,gene,1
gnas,gnas,gene,1
rnf43,rnf43,gene,1
muc1,muc1,gene,1
pelp1,pelp1,gene,1
genetic testing,genetic testing,diagnosis,1
pancreatic intraepithelial neoplasia,pancreatic intraepithelial neoplasia,cause,1
pancreatic mucinous cystadenoma,pancreatic mucinous cystadenoma,cause,1
pancreatic intraductal tubulopapillary neoplasm,pancreatic intraductal tubulopapillary neoplasm,cause,1
cdkn2a gene mutation,cdkn2a gene mutation,cause,1
smad4 gene mutation,smad4 gene mutation,cause,1
chronic pancreatitis,chronic pancreatitis,cause,1
hereditary pancreatitis,hereditary pancreatitis,cause,1
peutz-jeghers syndrome,peutz-jeghers syndrome,cause,1
von hippel-lindau disease,von hippel-lindau disease,cause,1
family history of prostate cancer,family history of prostate cancer,risk_factor,16
pancreatic adenocarcinoma,pancreatic adenocarcinoma,subtype,1
pancreatic ductal adenocarcinoma,pancreatic ductal adenocarcinoma,subtype,1
acinar cell carcinoma,acinar cell carcinoma,subtype,11
cystadenocarcinoma,cystadenocarcinoma,subtype,11
pancreatoblastoma,pancreatoblastoma,subtype,1
hepatoid adenocarcinoma,hepatoid adenocarcinoma,subtype,1
colon carcinoma,colon carcinoma,subtype,1
undifferentiated carcinoma with osteoclast-like giant cells,undifferentiated carcinoma with osteoclast-like giant cells,subtype,1
obsolete papillary cystic tumor,obsolete papillary cystic tumor,subtype,1
advanced pancreatic neuroendocrine tumor,advanced pancreatic neuroendocrine tumor,subtype,1
insulinoma,insulinoma,subtype,1
gastrinoma,gastrinoma,subtype,1
clinical history,clinical history,diagnosis,1
pathology,pathology,diagnosis,1
long-term follow-up,long-term follow-up,treatment,3
sdhd,sdhd,gene,3
sdha,sdha,gene,3
sdhc,sdhc,gene,3
sdhb,sdhb,gene,3
sdhaf2,sdhaf2,gene,3
tmem127,tmem127,gene,3
max,max,gene,3
slc25a11,slc25a11,gene,3
histochemistry,histochemistry,diagnosis,3
head and neck paraganglioma,head and neck paraganglioma,subtype,3
vagal paraganglioma,vagal paraganglioma,subtype,3
laryngeal paraganglioma,laryngeal paraganglioma,subtype,3
thyroid gland paraganglioma,thyroid gland paraganglioma,subtype,3
bladder paraganglioma,bladder paraganglioma,subtype,3
parathyroid carcinoma,parathyroid carcinoma,disease,1
hyperparathyroidism-jaw tumor syndrome,hyperparathyroidism-jaw tumor syndrome,risk_factor,1
penile cancer,penile cancer,disease,2
condyloma acuminatum,condyloma acuminatum,cause,2
phimosis,phimosis,risk_factor,2
anogenital venereal wart,anogenital venereal wart,risk_factor,2
balanitis,balanitis,risk_factor,2
paraphimosis,paraphimosis,risk_factor,2
basal cell carcinoma,basal cell carcinoma,subtype,2
vasopressor,vasopressor,treatment,3
epas1,epas1,gene,3
sox10,sox10,gene,3
s100b,s100b,gene,3
th,th,gene,3
dbh,dbh,gene,3
chat,chat,gene,3
mki67,mki67,gene,3
chromogranin,chromogranin,diagnosis,3
chromaffin cell,chromaffin cell,cause,3
neurofibromatosis 1,neurofibromatosis 1,risk_factor,3
carney triad,carney triad,risk_factor,3
carney-stratakis syndrome,carney-stratakis syndrome,risk_factor,3
adrenal gland pheochromocytoma,adrenal gland pheochromocytoma,subtype,3
extra-adrenal pheochromocytoma,extra-adrenal pheochromocytoma,subtype,3
malignant pheochromocytoma,malignant pheochromocytoma,subtype,3
aip,aip,gene,9
gpr101,gpr101,gene,9
growth hormone secreting pituitary adenoma,growth hormone secreting pituitary adenoma,cause,9
prolactinoma,prolactinoma,subtype,9
acth-secreting pituitary adenoma,acth-secreting pituitary adenoma,subtype,9
autologous stem cell transplantation,autologous stem cell transplantation,treatment,7
intensive chemotherapy,intensive chemotherapy,treatment,7
secondary plasma cell leukemia,secondary plasma cell leukemia,subtype,7
primary peritoneal cancer,primary peritoneal cancer,disease,9
serous surface papillary carcinoma,serous surface papillary carcinoma,subtype,9
ovarian serous carcinoma,ovarian serous carcinoma,subtype,9
endometrial serous adenocarcinoma,endometrial serous adenocarcinoma,subtype,9
fallopian tube serous adenocarcinoma,fallopian tube serous adenocarcinoma,subtype,9
cervical serous adenocarcinoma,cervical serous adenocarcinoma,subtype,9
prostate cancer,prostate cancer,disease,16
observation,observation,treatment,16
prior active surveillance,prior active surveillance,treatment,16
hoxb13,hoxb13,gene,16
cyp3a4,cyp3a4,gene,16
tmprss2,tmprss2,gene,16
erg,erg,gene,16
foxa1,foxa1,gene,16
biopsy of prostate,biopsy of prostate,diagnosis,16
gleason score 6,gleason score 6,diagnosis,16
prostate health index,prostate health index,diagnosis,16
4kscore,4kscore,diagnosis,16
african american,african american,risk_factor,16
castration-sensitive prostate carcinoma,castration-sensitive prostate carcinoma,subtype,16
thermotherapy,thermotherapy,treatment,8
red reflex test,red reflex test,diagnosis,8
eye examination,eye examination,diagnosis,8
lumbar puncture,lumbar puncture,diagnosis,8
rb1 gene mutation,rb1 gene mutation,cause,8
mycn gene mutation,mycn gene mutation,cause,8
short somatic mutation,short somatic mutation,cause,8
sporadic retinoblastoma,sporadic retinoblastoma,subtype,8
unilateral retinoblastoma,unilateral retinoblastoma,subtype,8
bilateral retinoblastoma,bilateral retinoblastoma,subtype,8
menin inhibitor,menin inhibitor,treatment,8
pax3,pax3,gene,8
pax7,pax7,gene,8
foxo1,foxo1,gene,8
myod1,myod1,gene,8
brd4,brd4,gene,8
igf2,igf2,gene,8
pi16,pi16,gene,8
electron microscopy,electron microscopy,diagnosis,8
abdominal,abdominal,diagnosis,8
costello syndrome,costello syndrome,risk_factor,8
noonan syndrome,noonan syndrome,risk_factor,8
dicer1 syndrome,dicer1 syndrome,risk_factor,8
embryonal rhabdomyosarcoma,embryonal rhabdomyosarcoma,subtype,8
alveolar rhabdomyosarcoma,alveolar rhabdomyosarcoma,subtype,8
pleomorphic rhabdomyosarcoma,pleomorphic rhabdomyosarcoma,subtype,8
botryoid rhabdomyosarcoma,botryoid rhabdomyosarcoma,subtype,8
radiograph,radiograph,diagnosis,11
orthopantomogram,orthopantomogram,diagnosis,11
chest radiography,chest radiography,diagnosis,11
epithelial malignant thymoma,epithelial malignant thymoma,subtype,11
pleomorphic adenoma,pleomorphic adenoma,subtype,11
warthin tumor,warthin tumor,subtype,11
myoepithelioma,myoepithelioma,subtype,11
basal cell adenoma,basal cell adenoma,subtype,11
oxyphilic adenoma,oxyphilic adenoma,subtype,11
sebaceous adenoma,sebaceous adenoma,subtype,11
intraductal papilloma,intraductal papilloma,subtype,11
cystadenoma,cystadenoma,subtype,11
mucoepidermoid carcinoma,mucoepidermoid carcinoma,subtype,11
epithelial-myoepithelial carcinoma,epithelial-myoepithelial carcinoma,subtype,11
"cervical adenocarcinoma, not otherwise specified","cervical adenocarcinoma, not otherwise specified",subtype,11
basophilic adenocarcinoma cell,basophilic adenocarcinoma cell,subtype,11
sebaceous adenocarcinoma,sebaceous adenocarcinoma,subtype,11
oncocytic adenocarcinoma,oncocytic adenocarcinoma,subtype,11
salivary duct carcinoma,salivary duct carcinoma,subtype,11
"salivary gland adenocarcinoma, not otherwise specified","salivary gland adenocarcinoma, not otherwise specified",subtype,11
"thymic adenocarcinoma, not otherwise specified","thymic adenocarcinoma, not otherwise specified",subtype,11
myoepithelial carcinoma,myoepithelial carcinoma,subtype,11
carcinoma ex pleomorphic adenoma,carcinoma ex pleomorphic adenoma,subtype,11
lymphoepithelioma-like carcinoma,lymphoepithelioma-like carcinoma,subtype,11
sialoblastoma,sialoblastoma,subtype,11
hemangioma,hemangioma,subtype,11
thyroid gland carcinoma,thyroid gland carcinoma,subtype,11
sialolipoma,sialolipoma,subtype,11
uterine cancer,uterine cancer,disease,9
serous carcinoma,serous carcinoma,disease,9
obsolete ovarian serous tumor,obsolete ovarian serous tumor,subtype,9
serous cystadenoma,serous cystadenoma,subtype,9
cystadenofibroma,cystadenofibroma,subtype,9
adenofibroma,adenofibroma,subtype,9
primary peritoneal serous adenocarcinoma,primary peritoneal serous adenocarcinoma,subtype,9
excessive blinking,excessive blinking,risk_factor,8
soft tissue sarcoma,soft tissue sarcoma,disease,8
liver angiosarcoma,liver angiosarcoma,subtype,8
synovial sarcoma,synovial sarcoma,subtype,8
alveolar soft part sarcoma,alveolar soft part sarcoma,subtype,8
undifferentiated pleomorphic sarcoma,undifferentiated pleomorphic sarcoma,subtype,8
testicular cancer,testicular cancer,disease,22
retroperitoneal lymph node dissection,retroperitoneal lymph node dissection,treatment,22
surveillance,surveillance,treatment,22
cryptorchidism,cryptorchidism,risk_factor,22
family history of testicular cancer,family history of testicular cancer,risk_factor,22
inguinal hernia,inguinal hernia,risk_factor,22
sedentary lifestyle,sedentary lifestyle,risk_factor,22
nonseminomatous,nonseminomatous,subtype,22
gonadoblastoma,gonadoblastoma,subtype,22
germinoma,germinoma,subtype,22
yolk sac tumor,yolk sac tumor,subtype,22
teratoma,teratoma,subtype,22
leydig cell tumor,leydig cell tumor,subtype,22
sertoli cell tumor,sertoli cell tumor,subtype,22
thymoma,thymoma,disease,9
serum protein electrophoresis,serum protein electrophoresis,diagnosis,9
electrolytes,electrolytes,diagnosis,9
renal function,renal function,diagnosis,9
thyroid cancer,thyroid cancer,disease,16
radioactive iodine therapy,radioactive iodine therapy,treatment,16
lenvatinib,lenvatinib,treatment,16
vandetanib,vandetanib,treatment,16
calcitonin measurement,calcitonin measurement,diagnosis,16
multiple endocrine neoplasia type 2,multiple endocrine neoplasia type 2,cause,16
thyroiditis,thyroiditis,cause,16
obsolete oxyphilic adenocarcinoma,obsolete oxyphilic adenocarcinoma,subtype,16
thyroid lymphoma,thyroid lymphoma,subtype,16
thymic squamous cell carcinoma,thymic squamous cell carcinoma,subtype,16
thyroid sarcoma,thyroid sarcoma,subtype,16
thyroid gland noninvasive follicular neoplasm with papillary-like nuclear features,thyroid gland noninvasive follicular neoplasm with papillary-like nuclear features,subtype,16
urethral cancer,urethral cancer,disease,7
medicine,medicine,treatment,7
urethral stricture,urethral stricture,cause,7
chronic inflammation,chronic inflammation,risk_factor,7
bladder urothelial papillary carcinoma,bladder urothelial papillary carcinoma,subtype,7
anterior urethra cancer,anterior urethra cancer,subtype,7
uterine sarcoma,uterine sarcoma,disease,9
hysteroscopy,hysteroscopy,diagnosis,9
vaginal cancer,vaginal cancer,disease,2
colposcopy,colposcopy,diagnosis,2
vaginal adenocarcinoma,vaginal adenocarcinoma,subtype,2
vulvar cancer,vulvar cancer,disease,2
intravenous pyelogram,intravenous pyelogram,diagnosis,2
vulvar intraepithelial neoplasia,vulvar intraepithelial neoplasia,cause,2
number of female sexual partners,number of female sexual partners,risk_factor,2
vulvar lichen sclerosus,vulvar lichen sclerosus,risk_factor,2
immunodeficiency syndrome,immunodeficiency syndrome,risk_factor,2
bartholin gland carcinoma,bartholin gland carcinoma,subtype,2
verrucous carcinoma,verrucous carcinoma,subtype,2
differentiated intraepithelial neoplasia,differentiated intraepithelial neoplasia,subtype,2
cutaneous paget's disease,cutaneous paget's disease,subtype,2
computed tomography,computed tomography,diagnosis,8
tissue sample,tissue sample,diagnosis,8
nephrogenic rest,nephrogenic rest,cause,8
